Editors' ChoiceCancer

JAK-ing up antibody delivery to cancer

See allHide authors and affiliations

Science Translational Medicine  03 Apr 2019:
Vol. 11, Issue 486, eaax1720
DOI: 10.1126/scitranslmed.aax1720

Abstract

The pan-JAK inhibitor tofacitinib improves the delivery of therapeutic antibodies in cancer.

View Full Text